Biggest News Aggregation in the World
📰 Leukemia News

Page 75 - Leukemia News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.

Optimal Sequencing of Therapy for Previously Treated Patients With Relapsed or Refractory ALL

Dr. Shah and colleagues dissect the social determinants of health, including limited personal resources, frailty, distance to treatment facilities, therapeutic compliance, and other considerations that impact effective treatment sequencing for patients with relapsed or refractory ALL, including access to care and CAR-T cell availability.
Optimal Sequencing Previously Treated Patients With Relapsed Acute Lymphoblastic Leukemia

Posttransplant Xospata Does Not Worsen Quality of Life in AML

While posttransplant Xospata did not worsen quality of life in patients with acute myeloid leukemia, it is essential that patients tell their providers about any side effects that they experience, an expert said.
Betty Hamilton Marrow Transplant Clinical Trials Network Cellular Therapy Meetings Functional Assessment Cancer Therapy Bone Marrow Transplant Acute Myeloid Leukemia

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.
United States John Paul Shen Neeraj Saini Scott Kopetz Daniel Frigo Richard Bouchard

Optimal Therapy Sequencing for Relapsed/Refractory ALL

Dr. Shah and colleagues dissect the social determinants of health, including limited personal resources, frailty, distance to treatment facilities, therapeutic compliance, and other considerations that impact effective treatment sequencing for patients with relapsed or refractory ALL, including access to care and CAR-T cell availability.
Recent Advances Acute Lymphoblastic Leukemia Therapy Sequencing

Emerging Therapies for the Older Patient With Acute Lymphoblastic Leukemia

Dr. Shah and faculty provide updates on emerging therapies, which exhibit promise for the treatment of relapsed or refractory acute lymphoblastic leukemia such as tisagenlecleucel and Obe-cel; obecabtagene autoleucel, preliminary outcomes of which were presented in the FELIX study at the 65th ASH Annual Meeting.
Recent Advances Acute Lymphoblastic Leukemia Older Patient With Acute Lymphoblastic

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science